NCT00001249
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 10, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Lymphoma, T-Cell, Cutaneous
Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.
387 public trials
42 recruiting studies
Lymphoma, T-Cell, Cutaneous trial results
NCT00400556
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cutaneous Lymphoma, +18 more
- Locations
-
- Peter MacCallum Cancer Center East Melbourne, Victoria, Australia
NCT00306969
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Boston University Medical Center Boston, Massachusetts, United States
Active, Not Recruiting
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
NCT05589896
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
- Locations
-
- City of Hope Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States
- Henry Ford Cancer Institute Detroit, Michigan, United States
Active, Not Recruiting
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
NCT01352520
- Conditions
- CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Cutaneous Lymphomas, Hematologic Diseases, +16 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
NCT02520791
- Conditions
- Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +29 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, Not Recruiting
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
NCT03602157
- Conditions
- Cutaneous Anaplastic Large Cell Lymphoma, Cutaneous Lymphoma, Cutaneous T Cell Lymphoma, +15 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Active, Not Recruiting
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
NCT00544115
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +95 more
- Locations
-
Not specified
Active, Not Recruiting
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
NCT05627245
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +24 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Yale University New Haven, Connecticut, United States
- University of Kansas Clinical Research Center Fairway, Kansas, United States
- University of Kansas Cancer Center Kansas City, Kansas, United States
Active, Not Recruiting
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
NCT02978625
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States